Souto E B, Wissing S A, Barbosa C M, Müller R H
Department of Pharmaceutics, Biopharmaceutics and Biotechnology, Free University of Berlin, Berlin, Germany.
Eur J Pharm Biopharm. 2004 Jul;58(1):83-90. doi: 10.1016/j.ejpb.2004.02.015.
Aqueous dispersions of lipid nanoparticles are being investigated as drug delivery systems for different therapeutic purposes. One of their interesting features is the possibility of topical use, for which these systems have to be incorporated into commonly used dermal carriers, such as creams or hydrogels, in order to have a proper semisolid consistency. For the present investigation four different gel-forming agents (xanthan gum, hydroxyethylcellulose 4000, Carbopol943 and chitosan) were selected for hydrogel preparation. Aqueous dispersions of lipid nanoparticles--solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC)--made from tripalmitin were prepared by hot high pressure homogenization and then incorporated into the freshly prepared hydrogels. NLC differ from SLN due to the presence of a liquid lipid (Miglyol812) in the lipid matrix. Lipid nanoparticles were physically characterized before and after their incorporation into hydrogels. By means of rheological investigations it could be demonstrated that physical properties of the dispersed lipid phase have a great impact on the rheological properties of the prepared semisolid formulations. By employing an oscillation frequency sweep test, significant differences in elastic response of SLN and NLC aqueous dispersions could be observed.
脂质纳米颗粒的水分散体正在作为用于不同治疗目的的药物递送系统进行研究。它们的一个有趣特性是可以局部使用,为此这些系统必须被掺入常用的皮肤载体中,如乳膏或水凝胶,以便具有适当的半固体稠度。在本研究中,选择了四种不同的凝胶形成剂(黄原胶、羟乙基纤维素4000、卡波姆943和壳聚糖)来制备水凝胶。由三棕榈酸甘油酯制成的脂质纳米颗粒——固体脂质纳米粒(SLN)和纳米结构脂质载体(NLC)——的水分散体通过热高压均质法制备,然后掺入新制备的水凝胶中。由于脂质基质中存在液态脂质(Miglyol812),NLC与SLN不同。脂质纳米颗粒在掺入水凝胶之前和之后进行了物理表征。通过流变学研究可以证明,分散脂质相的物理性质对所制备的半固体制剂的流变性质有很大影响。通过进行振荡频率扫描测试,可以观察到SLN和NLC水分散体弹性响应的显著差异。
Eur J Pharm Biopharm. 2004-7
Eur J Pharm Biopharm. 2004-11
Adv Drug Deliv Rev. 2007-7-10
Antioxidants (Basel). 2025-5-8
Biomimetics (Basel). 2024-12-27
Int J Pharm X. 2024-7-1
Front Cell Infect Microbiol. 2023
Pharmaceutics. 2023-9-27
Drug Deliv Transl Res. 2024-3
Saudi Pharm J. 2022-1